SEC Form 4 · accession 0001209191-16-136307
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter J Arduini
Officer — President & CEO · Director
Period of report
Aug 8, 2016
Accepted (ET)
Aug 10, 2016 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 8, 2016 | S | 4,009 | $84.7686 | D | 29,602 | D | |
| Common Stock | Aug 8, 2016 | M | 7,991 | $27.78 | A | 37,593 | D | |
| Common StockF3 | Aug 8, 2016 | S | 7,991 | $84.1894 | D | 29,602 | D | |
| Common Stock | Aug 9, 2016 | M | 12,009 | $27.78 | A | 41,611 | D | |
| Common StockF4 | Aug 9, 2016 | S | 12,009 | $84.6496 | D | 29,602 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F6,F5 | $27.78 | Aug 8, 2016 | M | 7,991 | D | — | Mar 1, 2020 | Common Stock | 7,991 | 207,803 | D |
| Non-Qualified Stock Option (right to buy)F5 | $27.78 | Aug 9, 2016 | M | 12,009 | D | — | Mar 1, 2020 | Common Stock | 12,009 | 195,794 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- F2The price shown above represents the weighted average price of the shares sold. The range of sale prices was $84.50 to $85.07.
- F3The price shown above represents the weighted average price of the shares sold. The range of sale prices was $83.90 to $84.61.
- F4The price shown above represents the weighted average price of the shares sold. The range of sale prices was $84.20 to $85.12.
- F5One-third of the stock options vested on the first anniversary of the grant date which is March 1, 2012 and thereafter with respect to the remaining two-thirds which vested in monthly installments through the 3rd anniversary of the grant date.
- F6This option was previously reported as covering 206,719 shares at an exercise price of $32.11 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.